PON1 Variants rs662 and rs854560: What They Mean

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on Blood Testing & Biomarkers. Browse all Blood Testing & Biomarkers education

The PON1 gene carries the instructions for paraoxonase-1, an enzyme that rides on HDL cholesterol particles and helps neutralize oxidized fats and certain environmental toxins. Two of its most studied single-nucleotide polymorphisms, rs662 and rs854560, change how well that enzyme works. This article explains what those variants do, why researchers connect them to cardiovascular and detoxification biology, and how pathway-level genetic context fits into a conversation with your provider.

What the PON1 gene does

Paraoxonase-1 is an antioxidant and hydrolytic enzyme made mainly in the liver and secreted into the bloodstream bound to high-density lipoprotein (HDL). In that position it does two jobs researchers care about: it slows the oxidation of LDL cholesterol, and it breaks down organophosphate compounds found in some pesticides and nerve agents. Because PON1 sits at the crossroads of lipid handling and chemical detoxification, small changes in the gene can ripple across several biological systems.

rs662 (Q192R): the activity switch

rs662, also written as the PON1 Q192R polymorphism, swaps glutamine (Q) for arginine (R) at position 192 of the protein. This position sits inside the enzyme's active site, so the substitution changes which substrates PON1 handles most efficiently. The R (192) form hydrolyzes paraoxon faster, while the Q (192) form is often more effective against certain oxidized lipids. Neither is simply 'good' or 'bad' — the variant shifts the enzyme's preferences rather than switching it off, which is why research findings vary by exposure and population.

rs854560 (L55M): the quantity dial

rs854560, the PON1 L55M polymorphism, replaces leucine (L) with methionine (M) at position 55. Rather than changing the active site, this variant influences how much stable enzyme is produced; the M (55) form is generally associated with lower serum PON1 concentration and activity. When rs662 and rs854560 are read together, they help explain the wide, roughly 40-fold range of PON1 activity seen across healthy people. Looking at a named variant like rs854560 in context is more informative than looking at either SNP alone.

Why researchers study these variants

Because paraoxonase-1 protects HDL and LDL from oxidation, epidemiological studies have examined whether PON1 genotype and activity associate with cardiovascular risk, with mixed but persistent signals. Other work looks at organophosphate metabolism in agricultural workers, where PON1 activity may shape how the body processes certain pesticide exposures. It is important to read this literature carefully: association is not causation, and a genotype describes a tendency across groups, not a verdict about any one person's health.

Lifestyle and PON1 activity

Genotype is only part of the picture. Research links PON1 activity to modifiable factors including diet, smoking, and oxidative stress. Diets rich in polyphenols and certain healthy fats have been associated with higher enzyme activity in some studies, while smoking is associated with lower activity. These are general, evidence-based observations about biology — not a treatment plan. Any decisions about diet, supplements, or toxin exposure belong in a discussion with a qualified healthcare provider who knows your full history.

How pathway-level genetics fits in

Knowing your PON1 variants will not diagnose a disease or tell you what to take. What it can do is add context to the antioxidant and detoxification pathways your body already runs. PlexusDx tells you about your biology; it does not tell you what to put in your body. That distinction is the whole point of pathway-level testing: it turns a blank slate into an informed starting point for a professional conversation.

Curious how your own DNA shapes these pathways? The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights to give you pathway-level context you can review with your provider. It reports on your biology — it does not tell you what to put in your body, diagnose any condition, or replace medical care.

Frequently Asked Questions

Are rs662 and rs854560 dangerous variants?

No single genotype is inherently dangerous. rs662 and rs854560 shift how much paraoxonase-1 you make and which substrates it favors. They describe tendencies studied across populations, not a diagnosis. Their real significance depends on lifestyle, exposures, and other genes, which is why context matters more than any one variant.

Does PON1 genotype predict heart disease?

It does not predict heart disease for an individual. Studies report associations between PON1 activity and cardiovascular biology, but associations across groups cannot forecast one person's outcome. Genetic context is one input among many, including blood biomarkers and clinical history that a healthcare provider weighs together.

Can I change my PON1 activity?

Your genotype is fixed, but research links measured PON1 enzyme activity to modifiable factors such as diet quality, smoking status, and oxidative stress. Any changes you consider should be discussed with a qualified provider, since general research findings are not a personalized prescription for you.

What does the PlexusDx test tell me about PON1?

The Precision Peptide Genetic Test reports pathway-level context about detoxification and antioxidant biology, including relevant variants. It informs a conversation with your provider. It does not diagnose any condition, predict drug response, or tell you what to put in your body.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, cure, manage, or prevent any disease or condition. Consult a qualified healthcare provider before beginning any peptide protocol or making changes to your health care.

This article is part of the PlexusDx Education Hub. Browse all Blood Testing & Biomarkers education